These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 865726)

  • 1. The clinical use of monthly injectable contraceptive preparations.
    Toppozada M
    Obstet Gynecol Surv; 1977 Jun; 32(6):335-47. PubMed ID: 865726
    [No Abstract]   [Full Text] [Related]  

  • 2. [Letter: Ovulation inhibitors in depot-form?].
    Lauritzen C
    MMW Munch Med Wochenschr; 1975 Feb; 117(9):361. PubMed ID: 804646
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive.
    Recio R; Garza-Flores J; Schiavon R; Reyes A; Diaz-Sanchez V; Valles V; Luz de la Cruz D; Oropeza G; Perez-Palacios G
    Contraception; 1986 Jun; 33(6):579-89. PubMed ID: 3769482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, double-blind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contraceptive combination of 90 mg dihydroxyprogesterone acetophenide and 6 mg estradiol enanthate.
    Coutinho EM; Spinola P; Barbosa I; Gatto M; Tomaz G; Morais K; Yazlle ME; de Souza RN; Pinho Neto JS; Leal Wde B; Leal C; Hippolito SB; Abranches AD
    Contraception; 1997 Mar; 55(3):175-81. PubMed ID: 9115007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroxyprogesterone acetophenide 150 mg + estradiol enantate 10 mg as monthly injectable contraceptives.
    Jarquín González JD; Elda de Aguirre L; Rodríguez C; Abrego de Aguilar M; Carrillo F; León DA; Lima M; Trigueros S; Acosta R
    Adv Contracept; 1996 Sep; 12(3):213-25. PubMed ID: 8910663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive.
    Schiavon R; Benavides S; Oropeza G; Garza-Flores J; Recio R; Díaz-Sanchez V; Pérez-Palacios G
    Contraception; 1988 Jun; 37(6):591-8. PubMed ID: 3396358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting injectable contraceptives.
    Vecchio TJ
    Adv Steroid Biochem Pharmacol; 1976; 5():1-64. PubMed ID: 779431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Single monthly injection for contraception].
    Artner J; Friedrich F
    Geburtshilfe Frauenheilkd; 1970 Jun; 30(6):554-64. PubMed ID: 5475938
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
    Giwa-Osagie OF
    Contraception; 1994 May; 49(5):421-33. PubMed ID: 8045129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
    Rahimy MH; Ryan KK
    Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives.
    Bassol S; Garza-Flores J
    Contraception; 1994 May; 49(5):441-53. PubMed ID: 8045131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable contraceptive, the promising alternative.
    Koetsawang S
    J Med Assoc Thai; 1975 Dec; 58(12):606-13. PubMed ID: 1206260
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contraceptive injection Depo-Provera, effect on bones and teenage girls].
    Edgardh K
    Tidsskr Nor Laegeforen; 2002 Dec; 122(30):2909-11. PubMed ID: 12569721
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy, acceptability, and clinical effects of a low-dose injectable contraceptive combination of dihydroxyprogesterone acetophenide and estradiol enanthate.
    Coutinho EM; Spinola P; Tomaz G; Morais K; Nassar de Souza R; Sabino Pinho Neto J; de Barros Leal W; Bomfim Hippolito S; D'Aurea Abranches A
    Contraception; 2000 Apr; 61(4):277-80. PubMed ID: 10899484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal bleeding patterns in users of Perlutal, a once-a-month injectable contraceptive consisting of 10 mg estradiol enanthate combined with 150 mg dihydroxyprogesterone acetophenide. A trial of 5462 woman-months.
    Martínez GH; Castañeda A; Correa JE
    Contraception; 1998 Jul; 58(1):21-7. PubMed ID: 9743892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical test with a prolonged-action estrogen-progesterone combination administered intramuscularly].
    Mateos Cándano M; Ochoa Bernal MR; Ruiz Moreno JA
    Ginecol Obstet Mex; 1969 Sep; 26(155):275-82. PubMed ID: 5402846
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contraception using 3-monthly injections of Depo-Provera].
    Revaz C; Welti H; Dettling A
    Gynakol Rundsch; 1978; 18(3-4):183-92. PubMed ID: 569623
    [No Abstract]   [Full Text] [Related]  

  • 20. Injectable long-acting progestogen contraception: a neglected modality.
    Rosenfield AG
    Am J Obstet Gynecol; 1974 Oct; 120(4):537-48. PubMed ID: 4606673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.